A study performed at Virginia Eye Consultants shows that daily dietary supplementation with a unique combination of omega fatty acids (GLA, EPA and DHA) for six months is effective in improving ocular irritation symptoms and halting the progressions of moderate to severe dry eye.
The clinical trial was conducted at Virginia Eye Consultants and at Baylor College of Medicine. Thirty-eight post-menopausal women with tear dysfunction in both eyes were evaluated. Participants randomly received HydroEye® (a proprietary blend of omega fatty acids, antioxidants and other nutrients) or a placebo every day. HydroEye® was found to improve ocular irritation symptoms, suppress ocular surface inflammation, and maintain corneal surface smoothness.
“Achieving statistical significance in a dry eye study is a remarkable accomplishment, especially given the extreme difficulty that many highly regarded pharmaceutical companies have had in bringing a prescription dry eye product to market,” said John D. Sheppard, M.D., M.M.Sc., president, Virginia Eye Consultants, professor of ophthalmology, clinical director of the Lee Laboratory for Ocular Pharmacology at Eastern Virginia Medical School, and co-principal investigator who initiated this research project. “This was a prospective, randomized, multicenter, placebo-controlled trial as would be any U.S. Food & Drug Administration registration clinical study.”
Dry eye disease is a multi-factorial disease that affects an estimated 25 million people in the United States alone. It is often under-recognized and under-diagnosed. Moderate to severe dry eye can significantly deteriorate the quality of life for those who suffer from the condition.
A wide variety of dry eye treatments are available, however many have disadvantages or side effects. If you’re suffering from dry eye, call Virginia Eye Consultants at 757-622-2200. We offer a variety of advanced treatments.
Sources: Science Based Health